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Technical Appendix 1 
Wildlife Rabies-related Costs (Details of Published Studies;  
No Inflation Corrections Used) 
A cost-comparison study examined expenditures for controlling rabies before (1988) and 
during (1990) a raccoon-variant rabies epizootic in Hunterdon and Warren counties, New Jersey, 
USA (1). This study examined perhaps the most diverse set of costs thus far reported, but these 
entailed relatively short-term, small-area estimates. The epizootic more than doubled rabies-
related control costs, from $4.05 ($359/km2) to $9.79/county resident ($913/km2, 1990 US$). 
Both before and during the epizootic, pet vaccinations were the largest single cost component of 
rabies expenses; the costs for vaccinations of domestic animals were $337,998/100,000 residents 
in 1988 and $640,552/100,000 residents in 1990. The next largest category was “other rabies 
control activities” (e.g., public health, public education) accounting for 11% of costs in 1988 and 
13% in 1990. The number of persons receiving postexposure prophylaxis (PEP) increased from 2 
in 1988 (1/100,000 residents) to 131 in 1990 (66/100,000 residents). Although the average cost 
was $555/person treated in 1988 and $1,138/person in 1990, PEPs only accounted for 8% of the 
rabies-related costs at the peak of the epizootic in New Jersey in 1999. 
In Massachusetts, a multiyear study focused on the increased use and cost of PEP during 
1991 (1 year before a rabies epizootic) and from 1992 through 1995 of a raccoon rabies epizootic 
in the state (2). The median cost of PEP was $2,376/person (range: $1,038–$4,447; 1995 US$); 
69% of the cost was due to biologics. Estimates were similar for Connecticut (3). Numbers of 
PEP administrations increased from 1.7/100,000 residents in 1991 to 45/100,000 residents in 
1995 (26-fold increase). Thus, this rabies epizootic increased PEP-related costs by 
$102,880/100,000 residents. 
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During the 1990s, New York State reported an epizootic of raccoon-variant rabies (4). 
The number of PEPs given in the state during the epizootic ranged from 2,422 in 1995 to a high 
of 3,373 in 1997 (no preepizootic numbers reported; New York City (NYC) is excluded from 
this statewide public health study). These are roughly equivalent to 24 and 34 PEPS per 100,000 
residents (calculated using 2000 census count of 10 million state residents, excluding NYC). The 
mean PEP cost was $1,136/person treated (1998 US$, biologics and administration), equivalent 
to between $27,264/100,000 and $38,624/100,000 residents. This amount is notably lower than 
the amount recorded in Massachusetts (2), but New York coordinates aspects of PEP (4). 
Recently (1998–2002), when a skunk rabies epizootic spread from San Luis Obispo to 
Santa Barbara County, the direct and indirect costs due to rabies exposure in southern California 
were documented, (5). County records documented the medical and public health activities 
required of 134 patients (equivalent to 4.1/100,000 county resident-years, using 2002 population 
estimates for 5 years). The public health costs included case investigations and animal control 
expenses. Telephone interviews of 55 patients who were given PEP provided indirect patient-
related expenses related to receiving PEP (e.g., alternative medicine, daycare, travel, time lost 
from work). The mean total cost of a suspected human rabies exposure was $3,688/patient; 
average direct (biologics, medical costs) and indirect costs were $2,564/patient and 
$1,124/patient, respectively (2005 US$). 
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